Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Hemoshear Therapeutics in August, 2015 for $1,199,998.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44GM113304-01A1 | Phase II | 1,199,998 | August 5, 2015 | |||||||
A SBIR Phase II contract was awarded to Hemoshear Therapeutics in September, 2016 for $1,210,475.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK100136-02A1 | Phase II | 1,210,475 | September 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Hemoshear Therapeutics in August, 2017 for $1,862,227.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DK115301-01 | Phase II | 1,862,227 | August 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Hemoshear Therapeutics in April, 2015 for $255,128.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK100136-01A1 | Phase I | 255,128 | April 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Hemoshear Therapeutics in March, 2015 for $463,475.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DK104456-01 | Phase I | 463,475 | March 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Hemoshear Therapeutics for $4,293,883.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL102951-02 | Phase II | 4,293,883 | ||||||||
A SBIR Phase I contract was awarded to Hemoshear Therapeutics for $249,013.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR001206-01 | Phase I | 249,013 | ||||||||
A SBIR Phase II contract was awarded to Hemoshear Therapeutics for $1,985,884.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201500023C-0-0-0 | Phase II | 1,985,884 | ||||||||
A SBIR Phase I contract was awarded to Hemoshear Therapeutics for $190,786.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK091104-01 | Phase I | 190,786 | ||||||||
A SBIR Phase I contract was awarded to Hemoshear Therapeutics for $166,830.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL102951-01 | Phase I | 166,830 |